JONATHAN LEWIS Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for JONATHAN LEWIS.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of JONATHAN LEWIS. JONATHAN LEWIS is CEO in ZIOPHARM ONCOLOGY INC ($ZIOP).
Latest Insider Trading Transactions of JONATHAN LEWIS
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan 02 2015 | ZIOP | ZIOPHARM ONCOLOGY ... | LEWIS JONATHAN | CEO | Option Exercise | A | 5.07 | 350,000 | 1,774,500 | 350,000 | |
| Jan 02 2015 | ZIOP | ZIOPHARM ONCOLOGY ... | LEWIS JONATHAN | CEO | Payment of Exercise | F | 5.03 | 34,261 | 172,333 | 744,145 | 778.4 K to 744.1 K (-4.40 %) |
| Jan 06 2014 | ZIOP | ZIOPHARM ONCOLOGY ... | LEWIS JONATHAN | CEO | Option Exercise | M | 0.08 | 242,979 | 19,438 | 0 | |
| Jan 06 2014 | ZIOP | ZIOPHARM ONCOLOGY ... | LEWIS JONATHAN | CEO | Option Exercise | M | 0.08 | 25,674 | 2,054 | 0 | |
| Jan 06 2014 | ZIOP | ZIOPHARM ONCOLOGY ... | LEWIS JONATHAN | CEO | Buy | M | 0.08 | 242,979 | 19,438 | 778,406 | 535.4 K to 778.4 K (+45.38 %) |
| Jan 06 2014 | ZIOP | ZIOPHARM ONCOLOGY ... | LEWIS JONATHAN | CEO | Buy | M | 0.08 | 25,674 | 2,054 | 535,427 | 509.8 K to 535.4 K (+5.04 %) |
| Jan 03 2014 | ZIOP | ZIOPHARM ONCOLOGY ... | LEWIS JONATHAN | CEO | Option Exercise | A | 4.34 | 300,000 | 1,302,000 | 300,000 | |
| Jan 03 2014 | ZIOP | ZIOPHARM ONCOLOGY ... | LEWIS JONATHAN | CEO | Payment of Exercise | F | 4.34 | 15,023 | 65,200 | 509,753 | 524.8 K to 509.8 K (-2.86 %) |
| Jun 28 2013 | ZIOP | ZIOPHARM ONCOLOGY ... | LEWIS JONATHAN | CEO | Option Exercise | A | 2.30 | 330,000 | 759,000 | 330,000 | |
| Jan 03 2013 | ZIOP | ZIOPHARM ONCOLOGY ... | LEWIS JONATHAN | CEO | Option Exercise | A | 4.16 | 300,000 | 1,248,000 | 300,000 | |
| Jan 03 2013 | ZIOP | ZIOPHARM ONCOLOGY ... | LEWIS JONATHAN | CEO | Payment of Exercise | F | 4.16 | 21,475 | 89,336 | 524,776 | 546.3 K to 524.8 K (-3.93 %) |
| Jan 03 2013 | ZIOP | ZIOPHARM ONCOLOGY ... | LEWIS JONATHAN | CEO | Payment of Exercise | F | 4.21 | 14,715 | 61,950 | 546,251 | 561 K to 546.3 K (-2.62 %) |
| Jan 04 2012 | ZIOP | ZIOPHARM ONCOLOGY ... | LEWIS JONATHAN | CEO | Payment of Exercise | F | 4.41 | 21,475 | 94,705 | 560,516 | 582 K to 560.5 K (-3.69 %) |
| Jan 04 2012 | ZIOP | ZIOPHARM ONCOLOGY ... | LEWIS JONATHAN | CEO | Grant | A | 0.00 | 102,781 | 0 | 581,991 | 479.2 K to 582 K (+21.45 %) |
Page: 1